CIK 0001811063 · Non-accelerated filer<br>Smaller reporting company
Nuvation Bio Inc.
Sign in to watch- Ticker
- NUVB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850862255
- Phone
- 332-208-6102
- Business address
- 1 PENNSYLVANIA PLAZA, SUITE 3805, NEW YORK, NY, 10019
- Former names
- Panacea Acquisition Corp
- 4 Grant or award SEE REMARKS acquired 50,761 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 25-NSE Other Notification of Removal from Listing
- 8-K Event Material agreement · Results of operations · Regulation FD disclosure
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 150,000 shares at $7.82 ($1,173,255)
- 144 Insider Sale of Securities
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 20,000 shares at an average $7.75 ($155,000)
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure · Other events
- 144 Insider Sale of Securities
Page 3 of 20 · 400 filings